Irish Drugmaker Sees Growth In P&G Acquisition Sep 25, 2009
It would roughly triple its annual revenue and quickly lift profits, take it into 14 new countries and add major products, including blockbuster osteoporosis drug Actonel and Asacol for ulcerative colitis ... Actonel brings in an estimated $1 billion in annual sales and Asacol about $600 million. (Investors Business Daily)
Warner Chilcott Buying P&G Drug Business for $3.1B Aug 25, 2009
The company also gets a colitis drug called Asacol with about $600 million in annual sales, a patent through 2014 and an extended release version just launching, plus Didronel for Paget's disease and other bone disorders and Enablex for overactive bladder. The deal is expected to close by year-end. (ABC News -- Wire)
Warner Chilcott to buy P&G drug business Aug 25, 2009
Warner Chilcott also gains colitis drug Asacol HD and bone drug Didronel in the deal. Warner Chilcott's products include oral contraceptives, skin products and hormone therapy creams. (MSNBC -- Business)
Warner Chilcott Said to Plan $3.1 Billion P&G Prescription Drug-Unit Deal Aug 24, 2009
The drugs unit makes Actonel, an osteoporosis drug, and Asacol, a colitis treatment, according to the Procter & Gamble. Procter & Gamble hired Goldman Sachs Group Inc. to find a buyer for the unit, a person with knowledge of the matter said earlier this year. (Bloomberg -- UK)
Zeria Pharmaceutical Agrees to Buy Switzerland's Tillotts for $128 Million Aug 4, 2009
Zeria will get rights to sell the drug Asacol in 53 countries in Europe and the Middle East, the Tokyo-based company said in a statement today ... Asacol is sold by Procter & Gamble Co. in the U.S., Moriyama said. (Bloomberg -- Japan)
Analysts see P&G Pharma as tough pill to swallow Mar 2, 2009
For one thing, the biggest drugs in the portfolio osteoporosis medication Actonel and the colitis drug Asacol have had flat to meager sales growth in the past 24 to 36 months, in part due to rising generic sales ... Asacol, meanwhile, has posted growth of less than 1 percent for most of the past two years ... This drug has the longest patent potential it doesn t expire until 2016, compared with 2013 for Actonel and Asacol. (Cincinnati Business Courier, OH)
